We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FTC Finalizes Rule Extending Reporting Requirements for Pharmaceutical Patent Transfers

08 November 2013

Antitrust, Competition and Economic Regulation Alert

On 6 November 2013 the Federal Trade Commission (FTC) announced final changes to certain Hart-Scott-Rodino (HSR) rules regarding acquisitions of exclusive patent rights in the pharmaceutical industry.

Read More: FTC Finalizes Rule Extending Reporting Requirements for Pharmaceutical Patent Transfers

The team

Loading data